nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—CYP3A4—Everolimus—kidney cancer	0.216	0.293	CbGbCtD
Tofisopam—CYP3A4—Temsirolimus—kidney cancer	0.146	0.198	CbGbCtD
Tofisopam—CYP3A4—Pazopanib—kidney cancer	0.0766	0.104	CbGbCtD
Tofisopam—CYP3A4—Erlotinib—kidney cancer	0.0547	0.0741	CbGbCtD
Tofisopam—CYP3A4—Paclitaxel—kidney cancer	0.05	0.0679	CbGbCtD
Tofisopam—CYP3A4—Sorafenib—kidney cancer	0.0444	0.0603	CbGbCtD
Tofisopam—CYP3A4—Vinblastine—kidney cancer	0.0439	0.0595	CbGbCtD
Tofisopam—CYP3A4—Vincristine—kidney cancer	0.0431	0.0585	CbGbCtD
Tofisopam—CYP3A4—Sunitinib—kidney cancer	0.036	0.0488	CbGbCtD
Tofisopam—CYP3A4—Doxorubicin—kidney cancer	0.027	0.0366	CbGbCtD
Tofisopam—Colchicine—ABCB1—kidney cancer	0.00161	0.691	CrCbGaD
Tofisopam—Verapamil—ABCB1—kidney cancer	0.000723	0.309	CrCbGaD
Tofisopam—PDE10A—Signaling Pathways—EIF4EBP1—kidney cancer	0.000304	0.00117	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HSPB1—kidney cancer	0.000304	0.00117	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—IL2—kidney cancer	0.000302	0.00116	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—SFRP2—kidney cancer	0.000298	0.00115	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—SFRP2—kidney cancer	0.00029	0.00111	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—ANXA1—kidney cancer	0.00029	0.00111	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—KRAS—kidney cancer	0.000288	0.00111	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000283	0.00109	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TSC1—kidney cancer	0.000283	0.00109	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PSMD7—kidney cancer	0.000283	0.00109	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ANXA1—kidney cancer	0.000283	0.00109	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—ANXA1—kidney cancer	0.000282	0.00108	CbGpPWpGaD
Tofisopam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000279	0.00107	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IGF2—kidney cancer	0.000274	0.00105	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—FLT1—kidney cancer	0.000274	0.00105	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CDKN2B—kidney cancer	0.000273	0.00105	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IGF1R—kidney cancer	0.000265	0.00102	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—PIK3CA—kidney cancer	0.000265	0.00102	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—POMC—kidney cancer	0.000258	0.000992	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—VEGFA—kidney cancer	0.000257	0.000986	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TP53—kidney cancer	0.000256	0.000983	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—RAF1—kidney cancer	0.000255	0.00098	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—JUNB—kidney cancer	0.000254	0.000975	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PAK1—kidney cancer	0.000254	0.000975	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—IL2—kidney cancer	0.000252	0.000967	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—MAPK3—kidney cancer	0.000243	0.000933	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—AKAP13—kidney cancer	0.00024	0.000923	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CASP2—kidney cancer	0.00024	0.000923	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—POMC—kidney cancer	0.000234	0.000901	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—AKAP13—kidney cancer	0.000234	0.000898	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CASP2—kidney cancer	0.000234	0.000898	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—MAPK1—kidney cancer	0.000231	0.000887	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000229	0.000881	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—IL2—kidney cancer	0.000229	0.000878	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—GRB7—kidney cancer	0.00022	0.000844	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—KRAS—kidney cancer	0.000218	0.000838	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HIF1A—kidney cancer	0.000218	0.000837	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TSC2—kidney cancer	0.000217	0.000835	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—GRB7—kidney cancer	0.000214	0.000821	CbGpPWpGaD
Tofisopam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000211	0.000811	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—KDR—kidney cancer	0.000208	0.000801	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IGF2—kidney cancer	0.000207	0.000797	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN2B—kidney cancer	0.000207	0.000794	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ITPR2—kidney cancer	0.000204	0.000785	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GSTT1—kidney cancer	0.000202	0.000775	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IGF1R—kidney cancer	0.000201	0.000771	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—PIK3CA—kidney cancer	0.0002	0.00077	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ITPR2—kidney cancer	0.000199	0.000764	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—RAF1—kidney cancer	0.000199	0.000763	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TP53—kidney cancer	0.000194	0.000745	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—RAF1—kidney cancer	0.000193	0.000743	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—KIT—kidney cancer	0.000192	0.000737	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—APC—kidney cancer	0.000192	0.000737	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—IL2—kidney cancer	0.000191	0.000733	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—PTGS1—kidney cancer	0.000189	0.000726	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CTNNA1—kidney cancer	0.000185	0.000712	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EIF4EBP1—kidney cancer	0.000184	0.000708	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HSPB1—kidney cancer	0.000184	0.000708	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—MAPK3—kidney cancer	0.000184	0.000706	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—POMC—kidney cancer	0.000183	0.000702	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—BRAF—kidney cancer	0.00018	0.000693	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CTNNA1—kidney cancer	0.00018	0.000692	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EIF4EBP1—kidney cancer	0.000179	0.000688	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HSPB1—kidney cancer	0.000179	0.000688	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—IL2—kidney cancer	0.000178	0.000684	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—MAPK1—kidney cancer	0.000175	0.000672	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—IL2—kidney cancer	0.000173	0.000666	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TSC1—kidney cancer	0.000171	0.000658	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PSMD7—kidney cancer	0.000171	0.000658	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ANXA1—kidney cancer	0.000171	0.000658	CbGpPWpGaD
Tofisopam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000171	0.000657	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—PIK3CA—kidney cancer	0.000167	0.000642	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PSMD7—kidney cancer	0.000167	0.00064	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ANXA1—kidney cancer	0.000167	0.00064	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TSC1—kidney cancer	0.000167	0.00064	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FLT1—kidney cancer	0.000166	0.000637	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—KRAS—kidney cancer	0.000165	0.000635	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HIF1A—kidney cancer	0.000165	0.000634	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TSC2—kidney cancer	0.000165	0.000633	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FLT1—kidney cancer	0.000161	0.00062	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—KDR—kidney cancer	0.000158	0.000607	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—POMC—kidney cancer	0.000156	0.000601	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PAK1—kidney cancer	0.000154	0.000591	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—JUNB—kidney cancer	0.000154	0.000591	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—POMC—kidney cancer	0.000152	0.000584	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PIK3CA—kidney cancer	0.000152	0.000583	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—VEGFA—kidney cancer	0.000151	0.000581	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RAF1—kidney cancer	0.000151	0.000579	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—RELA—kidney cancer	0.00015	0.000576	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—JUNB—kidney cancer	0.00015	0.000575	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PAK1—kidney cancer	0.00015	0.000575	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ERBB2—kidney cancer	0.000149	0.000573	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MTOR—kidney cancer	0.000147	0.000565	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—APC—kidney cancer	0.000145	0.000559	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—KIT—kidney cancer	0.000145	0.000559	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—MAPK3—kidney cancer	0.000143	0.00055	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—POMC—kidney cancer	0.000142	0.000546	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GSTP1—kidney cancer	0.00014	0.000537	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—MAPK3—kidney cancer	0.000139	0.000535	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—POMC—kidney cancer	0.000138	0.000532	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—POMC—kidney cancer	0.000138	0.000531	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CDKN1B—kidney cancer	0.000138	0.00053	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	0.000138	0.00053	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—BRAF—kidney cancer	0.000137	0.000525	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—MAPK1—kidney cancer	0.000136	0.000523	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL2—kidney cancer	0.000135	0.000519	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—MAPK1—kidney cancer	0.000133	0.000509	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCND1—kidney cancer	0.000132	0.000506	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—JUN—kidney cancer	0.000131	0.000505	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CTNNB1—kidney cancer	0.00013	0.000501	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—KRAS—kidney cancer	0.000129	0.000494	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—GSTM1—kidney cancer	0.000129	0.000494	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTEN—kidney cancer	0.000127	0.000488	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	0.000127	0.000487	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PIK3CA—kidney cancer	0.000127	0.000487	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF2—kidney cancer	0.000126	0.000483	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—KRAS—kidney cancer	0.000125	0.000481	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN2B—kidney cancer	0.000125	0.000481	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF2—kidney cancer	0.000122	0.00047	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	0.000122	0.000468	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN2B—kidney cancer	0.000122	0.000468	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IGF1R—kidney cancer	0.000122	0.000467	CbGpPWpGaD
Tofisopam—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	0.00012	0.000462	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IGF1R—kidney cancer	0.000118	0.000454	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—PIK3CA—kidney cancer	0.000118	0.000454	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—RAF1—kidney cancer	0.000117	0.00045	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—IL2—kidney cancer	0.000116	0.000444	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PIK3CA—kidney cancer	0.000115	0.000442	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—VEGFA—kidney cancer	0.000115	0.000441	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TP53—kidney cancer	0.000114	0.000439	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RAF1—kidney cancer	0.000114	0.000439	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—RAF1—kidney cancer	0.000114	0.000438	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—RELA—kidney cancer	0.000114	0.000437	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ERBB2—kidney cancer	0.000113	0.000434	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—IL2—kidney cancer	0.000112	0.000432	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MTOR—kidney cancer	0.000111	0.000428	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MAPK3—kidney cancer	0.000109	0.000417	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ACY1—kidney cancer	0.000107	0.000412	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MYC—kidney cancer	0.000106	0.000406	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—IL2—kidney cancer	0.000105	0.000403	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CDKN1B—kidney cancer	0.000105	0.000402	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MAPK1—kidney cancer	0.000103	0.000397	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL2—kidney cancer	0.000102	0.000393	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—IL2—kidney cancer	0.000102	0.000392	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HIF1A—kidney cancer	0.0001	0.000384	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TSC2—kidney cancer	9.98e-05	0.000383	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCND1—kidney cancer	9.98e-05	0.000383	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—JUN—kidney cancer	9.96e-05	0.000383	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CTNNB1—kidney cancer	9.88e-05	0.00038	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—KRAS—kidney cancer	9.76e-05	0.000375	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HIF1A—kidney cancer	9.73e-05	0.000374	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TSC2—kidney cancer	9.71e-05	0.000373	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTEN—kidney cancer	9.63e-05	0.00037	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KDR—kidney cancer	9.57e-05	0.000368	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KDR—kidney cancer	9.31e-05	0.000358	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PDHB—kidney cancer	9.12e-05	0.00035	CbGpPWpGaD
Tofisopam—CYP3A4—Biological oxidations—POMC—kidney cancer	9.09e-05	0.000349	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PIK3CA—kidney cancer	8.97e-05	0.000344	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KIT—kidney cancer	8.82e-05	0.000339	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—APC—kidney cancer	8.82e-05	0.000339	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—VEGFA—kidney cancer	8.7e-05	0.000334	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TP53—kidney cancer	8.68e-05	0.000333	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KIT—kidney cancer	8.58e-05	0.000329	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—APC—kidney cancer	8.58e-05	0.000329	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CCBL1—kidney cancer	8.57e-05	0.000329	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MAPK3—kidney cancer	8.44e-05	0.000324	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—POMC—kidney cancer	8.39e-05	0.000322	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—BRAF—kidney cancer	8.29e-05	0.000318	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAPK3—kidney cancer	8.23e-05	0.000316	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MAPK3—kidney cancer	8.21e-05	0.000315	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—POMC—kidney cancer	8.16e-05	0.000314	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—BRAF—kidney cancer	8.06e-05	0.00031	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MAPK1—kidney cancer	8.03e-05	0.000309	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MYC—kidney cancer	8.01e-05	0.000308	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAPK1—kidney cancer	7.83e-05	0.000301	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MAPK1—kidney cancer	7.81e-05	0.0003	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PIK3CA—kidney cancer	7.68e-05	0.000295	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—KRAS—kidney cancer	7.59e-05	0.000291	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PIK3CA—kidney cancer	7.47e-05	0.000287	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GLIPR1—kidney cancer	7.43e-05	0.000285	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PPAT—kidney cancer	7.43e-05	0.000285	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—KRAS—kidney cancer	7.4e-05	0.000284	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—KRAS—kidney cancer	7.38e-05	0.000283	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PIK3CA—kidney cancer	6.97e-05	0.000268	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RAF1—kidney cancer	6.92e-05	0.000266	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—FH—kidney cancer	6.91e-05	0.000265	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—APRT—kidney cancer	6.91e-05	0.000265	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—RELA—kidney cancer	6.89e-05	0.000265	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ERBB2—kidney cancer	6.84e-05	0.000263	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PIK3CA—kidney cancer	6.8e-05	0.000261	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PIK3CA—kidney cancer	6.78e-05	0.00026	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MTOR—kidney cancer	6.75e-05	0.000259	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RAF1—kidney cancer	6.73e-05	0.000259	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—RELA—kidney cancer	6.7e-05	0.000257	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ERBB2—kidney cancer	6.66e-05	0.000256	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TP53—kidney cancer	6.57e-05	0.000253	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MTOR—kidney cancer	6.57e-05	0.000252	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GPC3—kidney cancer	6.5e-05	0.000249	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CDKN1B—kidney cancer	6.34e-05	0.000243	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CA2—kidney cancer	6.32e-05	0.000243	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL2—kidney cancer	6.2e-05	0.000238	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CDKN1B—kidney cancer	6.17e-05	0.000237	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALAD—kidney cancer	6.16e-05	0.000237	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCND1—kidney cancer	6.05e-05	0.000232	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL2—kidney cancer	6.03e-05	0.000232	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—JUN—kidney cancer	6.03e-05	0.000232	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.01e-05	0.000231	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CTNNB1—kidney cancer	5.99e-05	0.00023	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCND1—kidney cancer	5.88e-05	0.000226	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.87e-05	0.000226	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—JUN—kidney cancer	5.87e-05	0.000225	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTEN—kidney cancer	5.84e-05	0.000224	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CTNNB1—kidney cancer	5.83e-05	0.000224	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTEN—kidney cancer	5.68e-05	0.000218	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PGK1—kidney cancer	5.63e-05	0.000216	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.63e-05	0.000216	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—LDHB—kidney cancer	5.52e-05	0.000212	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—VEGFA—kidney cancer	5.27e-05	0.000203	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—VEGFA—kidney cancer	5.13e-05	0.000197	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAPK3—kidney cancer	4.99e-05	0.000192	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAPK3—kidney cancer	4.85e-05	0.000186	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MYC—kidney cancer	4.85e-05	0.000186	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CA9—kidney cancer	4.79e-05	0.000184	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAPK1—kidney cancer	4.75e-05	0.000182	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MYC—kidney cancer	4.72e-05	0.000181	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAPK1—kidney cancer	4.62e-05	0.000177	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—KRAS—kidney cancer	4.48e-05	0.000172	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—KRAS—kidney cancer	4.36e-05	0.000167	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CA—kidney cancer	4.12e-05	0.000158	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CRABP1—kidney cancer	4.07e-05	0.000156	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CA—kidney cancer	4.01e-05	0.000154	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TP53—kidney cancer	3.98e-05	0.000153	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TP53—kidney cancer	3.87e-05	0.000149	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ITPR2—kidney cancer	3.79e-05	0.000145	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ACHE—kidney cancer	3.45e-05	0.000133	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTT1—kidney cancer	3.45e-05	0.000133	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SCARB1—kidney cancer	3.27e-05	0.000126	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS1—kidney cancer	3.23e-05	0.000124	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PSMD7—kidney cancer	3.17e-05	0.000122	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—BCHE—kidney cancer	3.01e-05	0.000116	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.97e-05	0.000114	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.87e-05	0.00011	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTP1—kidney cancer	2.39e-05	9.19e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ABCB1—kidney cancer	2.26e-05	8.7e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—GSTM1—kidney cancer	2.2e-05	8.45e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.08e-05	8.01e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—POMC—kidney cancer	1.55e-05	5.97e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTGS2—kidney cancer	1.24e-05	4.76e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTEN—kidney cancer	1.08e-05	4.15e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.63e-06	2.93e-05	CbGpPWpGaD
